Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
WW International, Inc. (NASDAQ: WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced access to Novo Nordisk's newly ...
A NovoCare® Recognized Care Provider, Weight Watchers’ new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone ...
H2Ocean’s sea salt based products. 2025 was a defining year for H2Ocean. From national recognition and scientific collaboration to manufacturing expansion, each milestone reflects our commitment to ...
To sum up, GH001 has shown us pretty robust efficacy, a strong safety profile, and durable antidepressant effects. Going into ...
Consumer Analysis Examines Multi-Form Magnesium Formulation, Quality Testing Protocols, and Research Context as New Year ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”) today announced that CEO Fabio Chianelli has published ...
By the beginning of 2025, it was clear the GLP-1 drugs were going to remain a major part of the industry. Pfizer used its presentation at the 43 rd JP Morgan Healthcre Conference to detail plans to ...
And, as we changed this means of interaction rather quickly, one way we did it has to do with games. Game engines are now AI ...
The first Modern Elder Cannabis Expo in Pheonix, AZ educated seniors about using medical cannabis therapeutically, ...
Energy is an indispensable part of modern society, acting as the foundation for nearly every aspect of daily life, including economic development, health, communication, and overall quality of life.
The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback